GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Hepalink Pharmaceutical Group Co Ltd (OTCPK:SHEZF) » Definitions » Cyclically Adjusted PB Ratio

Shenzhen Hepalink Pharmaceutical Group Co (Shenzhen Hepalink Pharmaceutical Group Co) Cyclically Adjusted PB Ratio : 1.14 (As of Jun. 09, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted PB Ratio?

As of today (2024-06-09), Shenzhen Hepalink Pharmaceutical Group Co's current share price is $0.7206. Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $0.63. Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio for today is 1.14.

The historical rank and industry rank for Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

SHEZF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.05   Med: 2.47   Max: 4.29
Current: 1.32

During the past years, Shenzhen Hepalink Pharmaceutical Group Co's highest Cyclically Adjusted PB Ratio was 4.29. The lowest was 1.05. And the median was 2.47.

SHEZF's Cyclically Adjusted PB Ratio is ranked better than
64.42% of 742 companies
in the Drug Manufacturers industry
Industry Median: 1.875 vs SHEZF: 1.32

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shenzhen Hepalink Pharmaceutical Group Co's adjusted book value per share data for the three months ended in Mar. 2024 was $1.142. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.63 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted PB Ratio Chart

Shenzhen Hepalink Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.90 2.52 2.45 1.79 1.62

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.91 1.59 1.69 1.62 1.14

Competitive Comparison of Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio falls into.



Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.7206/0.63
=1.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Shenzhen Hepalink Pharmaceutical Group Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.142/115.2271*115.2271
=1.142

Current CPI (Mar. 2024) = 115.2271.

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.989 98.200 1.160
201409 1.035 98.900 1.206
201412 1.044 99.000 1.215
201503 1.067 99.900 1.231
201506 1.056 99.500 1.223
201509 1.018 100.500 1.167
201512 1.056 100.600 1.210
201603 1.024 102.200 1.155
201606 0.955 101.400 1.085
201609 0.960 102.400 1.080
201612 0.924 102.600 1.038
201703 0.930 103.200 1.038
201706 0.886 103.100 0.990
201709 0.920 104.100 1.018
201712 0.946 104.500 1.043
201803 0.951 105.300 1.041
201806 0.947 104.900 1.040
201809 0.683 106.600 0.738
201812 0.710 106.500 0.768
201903 0.790 107.700 0.845
201906 0.764 107.700 0.817
201909 0.770 109.800 0.808
201912 0.840 111.200 0.870
202003 0.875 112.300 0.898
202006 0.878 110.400 0.916
202009 1.126 111.700 1.162
202012 1.206 111.500 1.246
202103 1.227 112.662 1.255
202106 1.233 111.769 1.271
202109 1.236 112.215 1.269
202112 1.221 113.108 1.244
202203 1.250 114.335 1.260
202206 1.225 114.558 1.232
202209 1.200 115.339 1.199
202212 1.204 115.116 1.205
202303 1.224 115.116 1.225
202306 1.180 114.558 1.187
202309 1.159 115.339 1.158
202312 1.137 114.781 1.141
202403 1.142 115.227 1.142

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shenzhen Hepalink Pharmaceutical Group Co  (OTCPK:SHEZF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Hepalink Pharmaceutical Group Co (Shenzhen Hepalink Pharmaceutical Group Co) Business Description

Traded in Other Exchanges
Address
No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading and biopharmaceutical research and development. The company distributes its products both in the domestic and overseas markets. The Group mainly operates three main business segments, including Finished dose pharmaceutical products business; Active pharmaceutical ingredients; CDMO business and Others. Geographical presence of company is in Hong Kong, United States of America, Europe, Mainland China and Other countries. Majority of the company's revenue comes from USA and Europe.

Shenzhen Hepalink Pharmaceutical Group Co (Shenzhen Hepalink Pharmaceutical Group Co) Headlines